PD-1/PD-L1 inhibitors can be associated with SJS/TEN-like eruptions, which unlike true SJS/TEN, evolve over weeks from milder morbilliform rashes (10, 18, 19). The gene discussed is PDCD1; the disease is toxic epidermal necrolysis.